Celebrating 75 years of BSACI

被引：0
|
作者：
Ewan, Pamela W. [1 ,2 ]
Durham, Stephen R. [3 ]
Scadding, Glenis K. [4 ,5 ]
Holgate, Stephen T. [6 ]
机构：
[1] Cambridge Univ Hosp NHS Trust, Allergy Dept, Cambridge, England
[2] Univ Cambridge, Clin Sch, Dept Med, Cambridge, England
[3] Imperial Coll, Natl Heart & Lung Inst, Allergy & Clin Immunol, London, England
[4] Royal Natl ENT Hosp, London, England
[5] UCL, Div Immun & Infect, London, England
[6] Southampton Univ Hosp Trust, Southampton, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2023年 / 53卷 / 12期
关键词：
TRIAL;
D O I：
10.1111/cea.14428
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1236 / 1238
页数：3
相关论文
共 50 条
  • [31] Thermal ablation of saphenous veins is feasible and safe in patients older than 75 years: A prospective study (EVTA study)
    Hamel-Desnos, C.
    Desnos, P.
    Allaert, F-A
    Kern, P.
    PHLEBOLOGY, 2015, 30 (08) : 525 - 532
  • [32] Response to an unsolicited intervention offer to persons aged ≥ 75 years after screening positive for depressive symptoms: a qualitative study
    van der Weele, Gerda M.
    de Jong, Roos
    de Waal, Margot W. M.
    Spinhoven, Philip
    Rooze, Herman A. H.
    Reis, Ria
    Assendelft, Willem J. J.
    Gussekloo, Jacobijn
    van der Mast, Roos C.
    INTERNATIONAL PSYCHOGERIATRICS, 2012, 24 (02) : 270 - 277
  • [33] Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study
    Wang, Mao Qiang
    Wang, Yan
    Yan, Jie Yu
    Yuan, Kai
    Zhang, Guo Dong
    Duan, Feng
    Li, Kai
    WORLD JOURNAL OF UROLOGY, 2016, 34 (09) : 1275 - 1283
  • [34] Alternating bortezomib-dexamethasone and lenalidomide- dexamethasone in patients with newly diagnosed multiple myeloma aged over 75 years
    Yokoyama, Akihiro
    Kada, Akiko
    Kagoo, Toshiya
    Hidake, Michihiro
    Iida, Hiroatsu
    Miyata, Yasuhiko
    Saito, Akiko M.
    Sawamura, Morio
    Komeno, Takuya
    Sunami, Kazutaka
    Takezako, Naoki
    Nagai, Hirokazu
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (01): : 80 - 90
  • [35] Treatment outcomes of hypofractionated radiotherapy combined with temozolomide followed by bevacizumab salvage therapy in glioblastoma patients aged > 75 years
    Matsuda, Ken-ichiro
    Sakurada, Kaori
    Nemoto, Kenji
    Kayama, Takamasa
    Sonoda, Yukihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 820 - 825
  • [36] Comparative One-Year Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients <75 Versus ≥75 Years With Unprotected Left Main Disease (from the CUSTOMIZE Registry)
    Capodanno, Davide
    Caggegi, Anna
    Capranzano, Piera
    Milino, Viviana
    Chisari, Alberto
    Mangiameli, Andrea
    Monaco, Sergio
    Barrano, Giombattista
    Di Salvo, Maria Elena
    Tamburino, Corrado
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (10) : 1452 - 1458
  • [37] Prostate Cancer Screening in Men 75 Years Old or Older: An Assessment of Self-Reported Health Status and Life Expectancy
    Hoffman, Karen E.
    Nguyen, Paul L.
    Ng, Andrea K.
    D'Amico, Anthony V.
    JOURNAL OF UROLOGY, 2010, 183 (05) : 1798 - 1802
  • [38] Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study
    Ingrosso, Gianluca
    Festa, Eleonora
    Caini, Saverio
    Ponti, Elisabetta
    Francolini, Giulio
    Doccioli, Chiara
    Lancia, Andrea
    Fondelli, Simona
    Santini, Roberto
    Valeriani, Maurizio
    Rago, Luciana
    Bruni, Alessio
    Augurio, Antonietta
    Trippa, Fabio
    Russo, Donatella
    Tamburo, Maria
    Parisi, Silvana
    Borghesi, Simona
    Gomellini, Sara
    Scoccianti, Silvia
    Musio, Daniela
    Stefanacci, Marco
    Facondo, Giuseppe
    Statuto, Teodora
    Miranda, Giulia
    Santo, Bianca
    Di Marzo, Alessandro
    Bellavita, Rita
    Vinciguerra, Annamaria
    Livi, Lorenzo
    Aristei, Cynthia
    Detti, Beatrice
    PROSTATE CANCER AND PROSTATIC DISEASES, 2025,
  • [39] Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide
    Gzell, C.
    Wheeler, H.
    Guo, L.
    Kastelan, M.
    Back, M.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (01) : 187 - 196
  • [40] Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older
    Ido, Keisuke
    Kurogi, Ryota
    Kurogi, Ai
    Nishimura, Kunihiro
    Arimura, Koichi
    Nishimura, Ataru
    Ren, Nice
    Kada, Akiko
    Matsuo, Ryu
    Onozuka, Daisuke
    Hagihara, Akihito
    Takagishi, So
    Yamagami, Keitaro
    Takegami, Misa
    Nohara, Yasunobu
    Nakashima, Naoki
    Kamouchi, Masahiro
    Date, Isao
    Kitazono, Takanari
    Iihara, Koji
    PLOS ONE, 2020, 15 (04):
12345